On the last day of the regular session, the Louisiana Legislature settled two major debates: A bill that would have banned ...

President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to ...

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

Kapil Dixit is a graduate of the Indian Institute of Mass Communications. He has covered crime at regional as well as state ...

Trump is correct. Too many drug prices are too high. How pharmacy benefit managers help inflate the prices of drugs in ...

Procuring lifesaving drugs is a daunting challenge in many low- and middle-income countries. Essential treatments are often ...

Medicaid doesn’t need price controls from other countries; it already imposes them here. Under the program’s existing “Best ...

The president promised lower prices on medications for Americans, but the state’s independent pharmacies doubt that will ...

A central dispute in the case is whether the chamber of commerce has legal standing to challenge the price controls.

New data from GoodRx Research reveals just how inadequate and restrictive prescription insurance has become. Medicaid, often ...

WASHINGTON — Senate health committee Chair Bill Cassidy (La.) is the latest Republican to take an interest in legislation ...

For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between segments. But a pair of policies being considered by Health and Human Services Secretary Robert F.